Translate

Pages

Pages

Pages

Intro Video

Wednesday, May 6, 2020

Gabrielle Union Talks About How Black Actors Are Feeling The Economic Repercussions Of COVID-19

gabrielle union

Many individuals have been uniquely impacted by the devastating effects of COVID-19, or the novel coronavirus, pandemic ranging from blue-collar workers to even NBA athletes. Actress Gabrielle Union is speaking out to talk about how her colleagues within black Hollywood are also feeling the economic ramifications of the public health crisis.

Due to COVID-19, all Hollywood productions have been shut down due to mandatory stay-at-home orders in various states to protect the crew and actors working on set. Union spoke on Instagram Live in a conversation with model Sharam Diniz to express how the shut down has negatively impacted working black actors amid the viral outbreak.

“For all of the Oprah [Winfrey]’s and the people who have just a lot a lot a lot a lot of money, most of us are one or two checks away from not having money to pay for all of our things, you know what I mean?” she revealed on the interview, according to Essence. “So this stoppage of work and money is impacting marginalized celebrities the most.”

Union also pointed out that while many celebrities have fame with thousands, or even millions, of followers on social media, it doesn’t mean they are wealthy noting that many project a luxe lifestyle on Instagram despite living in a different reality. According to some data, the average Hollywood actor made about $44,984 in 2016.

“All those influencers you see…who seem to be everywhere, they may not have a lot of liquid income,” Union continued. “You can’t charge your rent. You have to pay your rent.”

Union continued the conversation on Twitter to explain that many actors are feeling the effects despite the glamorous lifestyle they may portray through social media.



from Black Enterprise https://ift.tt/3fq8koJ
via

Nikon D780 Review: Jack of All Trades

The company's newest full-frame DSLR shows there's still a place for big, powerful cameras.

from Wired https://ift.tt/2zf5Ngq
via

Covid-19 Forces Spring Science Field Work to Go Fallow

Researchers and graduate students who depend on outdoor data collection find themselves stuck inside, just as expedition season normally gets going.

from Wired https://ift.tt/3bbaEMQ
via

'Upload' Is a Clunky Parable About Class in a Digital Afterlife

The Amazon comedy has a smart premise, but it's light on ambition.

from Wired https://ift.tt/3dquBB3
via

China Is One Launch Closer to Building Its Own Space Station

The success of the Long March 5B rocket marked the country's latest attempt to position itself as an equal to NASA in space.

from Wired https://ift.tt/3cbGRoF
via

After 60 Years, Explosion-Powered Rockets Are Nearly Here

Rotating detonation engines could make rockets lighter, faster, and simpler. First imagined in the 1950s, now they’re almost ready for their first flight.

from Wired https://ift.tt/35FI05E
via

‘Iron Man’ Actor Charged With Federal Fraud for Peddling Fake COVID-19 Cure

Iron Man actor Keith L. Middlebrook

We now have reportedly the first person arrested and charged for trying to peddle a miracle drug that is supposed to cure the coronavirus. Actor and bodybuilder Keith L. Middlebrook from Los Angeles is the first person in the United States to be charged with a federal crime for peddling a fake cure for COVID-19 while also promising big returns to his investors, according to AARP.

in a detailed 20-page affidavit from an FBI special agent, Middlebrook, 52, who has about 2.4 million followers on his Instagram account, concocted a deceitful web of lies and was hawking a cure for the respiratory disease caused by the novel coronavirus.

Authorities say the actor, who had small roles in Iron Man 2, Iron Man 3, and Thor is behind bars and charged with attempted wire fraud. He is due back in court on May 22. On Instagram, he labeled himself as the “Real Iron Man” and a “Genius Entrepreneur Icon.”

Middlebrook is accused of scheming to defraud investors by promising enormous returns on investments in the firm he owns, Quantum Prevention CV Inc. He then allegedly claimed he developed a patent-pending cure for COVID-19 and was also touting a treatment that he said would prevent a person from contracting the virus. He posted on Instagram that a serum had been developed and when injected, the serum would cure a person with the disease within 24 hours and also a pill that would prevent a person from contracting the virus. He made similar claims on YouTube as well.

Recently, the FDA gave emergency approval for the antiviral drug remdesivir for the treatment of COVID-19.

After Middlebrook had been charged, Nick Hanna, the U.S. Attorney in Los Angeles, said in a written statement: “During these difficult days, scams like this are using blatant lies to prey upon our fears and weaknesses. … I again am urging everyone to be extremely wary of outlandish medical claims and false promises of immense profits. And to those who perpetrate these schemes, know that federal authorities are out in force to protect all Americans, and we will move aggressively against anyone seeking to cheat the public during this critical time.”



from Black Enterprise https://ift.tt/3ccNZB6
via

Who Invented the Wheel? And How Did They Do It?

The wagon—and the wagon wheel—could not have been put together in stages. Either it works, or it doesn’t. And it enabled humans to spread rapidly into huge parts of the world.

from Wired https://ift.tt/2SHj7Rx
via

The H1N1 Crisis Predicted Covid-19’s Toll on Black Americans

In 2009, nonwhite patients got sicker faster, recovered more slowly, and died at higher rates than white patients. Now history is repeating itself.

from Wired https://ift.tt/2L6tXfK
via

Pandemic Lessons From an 18th Century Reenactor

In all ways, Jon Townsend lives an old-fashioned life. Except, maybe, when he uploads portions of it to his endearing—and instructive—YouTube channel.

from Wired https://ift.tt/3fsaMuG
via

Coronavirus: Most Africans 'will go hungry in 14-day lockdown'

A survey finds that there is a risk of unrest and violence if coronavirus restrictions are too harsh.

from BBC News - Africa https://ift.tt/2Wwqb4z
via

Tuesday, May 5, 2020

Coronavirus: Ethiopia cancels all football competitions

Ethiopia voids its season, with no promotion or relegation, in response to coronavirus.

from BBC News - Africa https://ift.tt/3dkWxpJ
via

Ta Lou: 'Life is more important than competitions'

Ivorian sprinter Marie-Josée Ta Lou says she does not want to race again until the coronavirus situation is 'settled'.

from BBC News - Africa https://ift.tt/3b7VNmv
via

Study finds stronger links between automation and inequality

This is part 3 of a three-part series examining the effects of robots and automation on employment, based on new research from economist and Institute Professor Daron Acemoglu. 

Modern technology affects different workers in different ways. In some white-collar jobs — designer, engineer — people become more productive with sophisticated software at their side. In other cases, forms of automation, from robots to phone-answering systems, have simply replaced factory workers, receptionists, and many other kinds of employees.

Now a new study co-authored by an MIT economist suggests automation has a bigger impact on the labor market and income inequality than previous research would indicate — and identifies the year 1987 as a key inflection point in this process, the moment when jobs lost to automation stopped being replaced by an equal number of similar workplace opportunities.

“Automation is critical for understanding inequality dynamics,” says MIT economist Daron Acemoglu, co-author of a newly published paper detailing the findings.

Within industries adopting automation, the study shows, the average “displacement” (or job loss) from 1947-1987 was 17 percent of jobs, while the average “reinstatement” (new opportunities) was 19 percent. But from 1987-2016, displacement was 16 percent, while reinstatement was just 10 percent. In short, those factory positions or phone-answering jobs are not coming back.

“A lot of the new job opportunities that technology brought from the 1960s to the 1980s benefitted low-skill workers,” Acemoglu adds. “But from the 1980s, and especially in the 1990s and 2000s, there’s a double whammy for low-skill workers: They’re hurt by displacement, and the new tasks that are coming, are coming slower and benefitting high-skill workers.”

The new paper, “Unpacking Skill Bias: Automation and New Tasks,” will appear in the May issue of the American Economic Association: Papers and Proceedings. The authors are Acemoglu, who is an Institute Professor at MIT, and Pascual Restrepo PhD ’16, an assistant professor of economics at Boston University.

Low-skill workers: Moving backward

The new paper is one of several studies Acemoglu and Restrepo have conducted recently examining the effects of robots and automation in the workplace. In a just-published paper, they concluded that across the U.S. from 1993 to 2007, each new robot replaced 3.3 jobs.

In still another new paper, Acemoglu and Restrepo examined French industry from 2010 to 2015. They found that firms that quickly adopted robots became more productive and hired more workers, while their competitors fell behind and shed workers — with jobs again being reduced overall.

In the current study, Acemoglu and Restrepo construct a model of technology’s effects on the labor market, while testing the model’s strength by using empirical data from 44 relevant industries. (The study uses U.S. Census statistics on employment and wages, as well as economic data from the Bureau of Economic Analysis and the Bureau of Labor Studies, among other sources.)

The result is an alternative to the standard economic modeling in the field, which has emphasized the idea of “skill-biased” technological change — meaning that technology tends to benefit select high-skilled workers more than low-skill workers, helping the wages of high-skilled workers more, while the value of other workers stagnates. Think again of highly trained engineers who use new software to finish more projects more quickly: They become more productive and valuable, while workers lacking synergy with new technology are comparatively less valued.  

However, Acemoglu and Restrepo think even this scenario, with the prosperity gap it implies, is still too benign. Where automation occurs, lower-skill workers are not just failing to make gains; they are actively pushed backward financially. Moreover,  Acemoglu and Restrepo note, the standard model of skill-biased change does not fully account for this dynamic; it estimates that productivity gains and real (inflation-adjusted) wages of workers should be higher than they actually are.

More specifically, the standard model implies an estimate of about 2 percent annual growth in productivity since 1963, whereas annual productivity gains have been about 1.2 percent; it also estimates wage growth for low-skill workers of about 1 percent per year, whereas real wages for low-skill workers have actually dropped since the 1970s.

“Productivity growth has been lackluster, and real wages have fallen,” Acemoglu says. “Automation accounts for both of those.” Moreover, he adds, “Demand for skills has gone down almost exclusely in industries that have seen a lot of automation.”

Why “so-so technologies” are so, so bad

Indeed, Acemoglu says, automation is a special case within the larger set of technological changes in the workplace. As he puts it, automation “is different than garden-variety skill-biased technological change,” because it can replace jobs without adding much productivity to the economy.

Think of a self-checkout system in your supermarket or pharmacy: It reduces labor costs without making the task more efficient. The difference is the work is done by you, not paid employees. These kinds of systems are what Acemoglu and Restrepo have termed “so-so technologies,” because of the minimal value they offer.

“So-so technologies are not really doing a fantastic job, nobody’s enthusiastic about going one-by-one through their items at checkout, and nobody likes it when the airline they’re calling puts them through automated menus,” Acemoglu says. “So-so technologies are cost-saving devices for firms that just reduce their costs a little bit but don’t increase productivity by much. They create the usual displacement effect but don’t benefit other workers that much, and firms have no reason to hire more workers or pay other workers more.”

To be sure, not all automation resembles self-checkout systems, which were not around in 1987. Automation at that time consisted more of printed office records being converted into databases, or machinery being added to sectors like textiles and furniture-making. Robots became more commonly added to heavy industrial manufacturing in the 1990s. Automation is a suite of technologies, continuing today with software and AI, which are inherently worker-displacing.

“Displacement is really the center of our theory,” Acemoglu says. “And it has grimmer implications, because wage inequality is associated with disruptive changes for workers. It’s a much more Luddite explanation.”

After all, the Luddites — British textile mill workers who destroyed machinery in the 1810s — may be synonymous with technophobia, but their actions were motivated by economic concerns; they knew machines were replacing their jobs. That same displacement continues today, although, Acemoglu contends, the net negative consequences of technology on jobs is not inevitable. We could, perhaps, find more ways to produce job-enhancing technologies, rather than job-replacing innovations.

“It’s not all doom and gloom,” says Acemoglu. “There is nothing that says technology is all bad for workers. It is the choice we make about the direction to develop technology that is critical.”



from MIT News https://ift.tt/3b5JtDm
via

Supreme Court says Justice Ruth Bader Ginsburg hospitalized with infection

WASHINGTON (AP) — Justice Ruth Bader Ginsburg was hospitalized Tuesday with an infection caused by a gallstone, the Supreme Court said.

The 87-year-old justice underwent non-surgical treatment for what the court described as acute cholecystitis, a benign gall bladder condition, at Johns Hopkins Hospital in Baltimore, Maryland.

READ MORE: Supreme Court throws wrench in Byron Allen’s $20B suit against Comcast 

She expects to be in the hospital for a day or two, the court said.

Ginsburg took part in the court’s telephone arguments Monday and Tuesday and plans to do so again Wednesday, the court said.

She has been treated four times for cancer, most recently in August.

She initially sought medical care Monday, when the gallstone was first diagnosed.

The post Supreme Court says Justice Ruth Bader Ginsburg hospitalized with infection appeared first on TheGrio.



from TheGrio https://ift.tt/35zmhfu
via

San Diego Sheriff’s Department Investigating Incident of Man in KKK Hood While at Vons’ Grocery

Vons KKK

The San Diego County Sheriff’s Department is investigating an incident involving a man wearing a Ku Klux Klan mask while shopping in a California Vons’ grocery store.

According to Essence, the incident took place on Saturday afternoon. The sheriff’s department condemned the incident and is investigating.

“The Sheriff’s Department is investigating,” Santee Mayor John Minto said Sunday. “I hope they will have more information for us tomorrow.”

Local officials have also condemned the incident, saying hate will not be tolerated. East County Supervisor Dianne Jacob called the situation “abhorrent.”

“This blatant racism has no place in Santee or any part of San Diego County,” Jacob said in a statement Sunday. “It is not who we are. It is not what we stand for and can’t be tolerated.”

Vons also released a statement, saying store employees asked the customer to remove the mask several times. Vons is also reviewing operations to ensure another incident does not happen.

“Unfortunately, an alarming and isolated incident occurred at our Vons store in Santee, where a customer chose an inflammatory method of wearing a face covering.” the release said. ” Needless to say, it was shocking.

“Several members of our team asked the customer to remove it, and all requests were ignored until the customer was in the checkout area. This was a disturbing incident for our associates and customers, and we are reviewing with our team how to best handle such inappropriate situations in the future.”

The incident was quickly shared on social media and according to the Times of San Diego, protests are being organized at the Vons location.

African Americans have been expressing their concerns about wearing face masks during the coronavirus pandemic. Sens. Kamala Harris and Cory Booker have asked the Justice Department to publish guidance to help local law enforcement.

Several supermarkets around the country have implemented policies requiring customers to wear face masks, but some have resisted.



from Black Enterprise https://ift.tt/2YDnXTM
via

This Pandemic Is Lonely. But Don't Call Loneliness an ‘Epidemic’

Comparing isolation to infection disease isn't helpful, says historian Fay Bound Alberti. But Covid-19 lends a unique opportunity to reframe the issue.

from Wired https://ift.tt/2yvRdRB
via

Best Nintendo Switch Deals and Console Bundles (May 2020)

The best Nintendo Switch console deals, and all the essentials you'll need when you own one.

from Wired https://ift.tt/2GPrBCl
via

Google and the Cost of 'Data Voids' During a Pandemic

Was a Nazi slogan brandished at a Reopen Illinois rally? The answer depends on what you search, and when you search for it.

from Wired https://ift.tt/3fmdrWO
via

SHERLOCK-based one-step test provides rapid and sensitive Covid-19 detection

A team of researchers at the McGovern Institute for Brain Research at MIT, the Broad Institute of MIT and Harvard, the Ragon Institute, and the Howard Hughes Medical Institute (HHMI) has developed a new diagnostics platform called STOP (SHERLOCK Testing in One Pot). The test can be run in an hour as a single-step reaction with minimal handling, advancing the CRISPR-based SHERLOCK diagnostic technology closer to a point-of-care or at-home testing tool. The test has not been reviewed or approved by the FDA and is currently for research purposes only.

The team began developing tests for COVID-19 in January after learning about the emergence of a new virus which has challenged the health care system in China. The first version of the team’s SHERLOCK-based Covid-19 diagnostics system is already being used in hospitals in Thailand to help screen patients for Covid-19 infection. 

The new test is named “STOPCovid” and is based on the STOP platform. In research, it has been shown to enable rapid, accurate, and highly sensitive detection of the Covid-19 virus SARS-CoV-2, with a simple protocol that requires minimal training and uses simple, readily available equipment, such as test tubes and water baths. STOPCovid has been validated in research settings using nasopharyngeal swabs from patients diagnosed with Covid-19. It has also been tested successfully in saliva samples to which SARS-CoV-2 RNA has been added as a proof of principle. 

The team is posting the open protocol today on a new website called STOPCovid.science. It is being made openly available in line with the COVID-19 Technology Access Framework organized by Harvard University, MIT, and Stanford University. The framework sets a model by which critically important technologies that may help prevent, diagnose, or treat Covid-19 infections may be deployed for the greatest public benefit without delay.

There is an urgent need for widespread, accurate COVID-19 testing to rapidly detect new cases, ideally without the need for specialized lab equipment. Such testing would enable early detection of new infections and drive effective “test-trace-isolate” measures to quickly contain new outbreaks. However, current testing capacity is limited by a combination of requirements for complex procedures and laboratory instrumentation, and dependence on limited supplies. STOPCovid can be performed without RNA extraction, and while all patient tests have been performed with samples from nasopharyngeal swabs, preliminary experiments suggest that eventually swabs may not be necessary. Removing these barriers could help enable broad distribution.

“The ability to test for Covid-19 at home, or even in pharmacies or places of employment, could be a game-changer for getting people safely back to work and into their communities,” says Feng Zhang, a co-inventor of the CRISPR genome editing technology, an investigator at the McGovern Institute and HHMI, and a core member at the Broad Institute. “Creating a point-of-care tool is a critically important goal to allow timely decisions for protecting patients and those around them.”

To meet this need, Zhang, McGovern Fellows Omar Abudayyeh and Jonathan Gootenberg, and their colleagues initiated a push to develop STOPCovid. They are sharing their findings and packaging reagents so other research teams can rapidly follow up with additional testing or development. The group is also sharing data on the StopCOVID.science website and via a submitted preprint. The website is also a hub where the public can find the latest information on the team’s developments. 

How it works

The STOPCovid test combines CRISPR enzymes, programmed to recognize signatures of the SARS-CoV-2 virus, with complementary amplification reagents. This combination allows detection of as few as 100 copies of SARS-CoV-2 virus in a sample. As a result, the STOPCovid test allows for rapid, accurate, and highly sensitive detection of Covid-19 that can be conducted outside clinical laboratory settings. 

STOPCovid has been tested on patient nasopharyngeal swab in parallel with clinically validated tests. In these head-to-head comparisons, STOPCovid detected infection with 97 percent sensitivity and 100 percent specificity. Results appear on an easy-to-read strip that is akin to a pregnancy test, in the absence of any expensive or specialized lab equipment. Moreover, the researchers spiked mock SARS-CoV-2 genomes into healthy saliva samples and showed that STOPCovid is capable of sensitive detection from saliva, which would obviate the need for swabs in short supply and potentially make sampling much easier.

“The test aims to ultimately be simple enough that anyone can operate it in low-resource settings, including in clinics, pharmacies, or workplaces, and it could potentially even be put into a turn-key format for use at home,” says Abudayyeh.

Gootenberg adds, “Since STOPCovid can work in less than an hour and does not require any specialized equipment, and if our preliminary results from testing synthetic virus in saliva bear out in patient samples, it could address the need for scalable testing to reopen our society.” 

Importantly, the full test — both the viral genome amplification and subsequent detection — can be completed in a single reaction, as outlined on the website, from swabs or saliva. To engineer this, the team tested a number of CRISPR enzymes to find one that works well at the same temperature needed by the enzymes that perform the amplification. Zhang, Abudayyeh, Gootenberg, and their teams, including graduate students Julia Joung and Alim Ladha, settled on a protein called AapCas12b, a CRISPR protein from the bacterium Alicyclobacillus acidophilus, responsible for the “off” taste associated with spoiled orange juice. With AapCas12b, the team was able to develop a test that can be performed at a constant temperature and does not require opening tubes midway through the process, a step that often leads to contamination and unreliable test results. 

Information sharing and next steps

The team has prepared reagents for 10,000 tests to share for free with scientists and clinical collaborators around the world who want to evaluate the STOPCovid test for potential diagnostic use, and they have set up a website to share the latest data and updates with the scientific and clinical community. Kits and reagents can also be requested via a form on the website. 

Patient samples were provided by Keith Jerome, Alex Greninger, Robert Bruneau, Mee-li W. Huang, Nam G. Kim, Xu Yu, Jonathan Li, and Bruce Walker. This work was supported by the Patrick J. McGovern Foundation and the McGovern Institute for Brain Research. F.Z is also supported by the NIH (1R01- MH110049 and 1DP1-HL141201 grants); Mathers Foundation; the Howard Hughes Medical Institute; Open Philanthropy Project; J. and P. Poitras; and R. Metcalfe.

Zhang, Abudayyeh, Gootenberg, Joung, and Ladha are inventors on patent applications related to this technology filed by the Broad Institute, with the specific aim of ensuring this technology can be made freely, widely, and rapidly available for research and deployment. Abudayyeh, Gootenberg, and Zhang are co-founders, scientific advisors, and hold equity interests in Sherlock Biosciences, Inc. Zhang is also a co-founder of Editas Medicine, Beam Therapeutics, Pairwise Plants, and Arbor Biotechnologies.



from MIT News https://ift.tt/2zadSmz
via